Mr. Goss, who has won several published Daubert decisions, often serves as “science counsel” in life sciences litigation. He collaborates with leading experts to present complex medical and scientific evidence, both in dispositive motions and at trial. He is a frequent commentator on scientific evidence and legal developments of interest to FDA-regulated industries.
Mr. Goss is devoted to pro bono and community service. He has served on the Board of Directors of Volunteer Lawyers Network, a Minneapolis-based civil legal services organization. since 2008, and served as Board Chair for the 2011-12 term.
•Benchmark LitigationMinnesota Litigation Star
•Best Lawyers in America (Mass Tort Litigation/Class Actions- Defendants; Product Liability Litigation- Defendants)
•Named a “Life Sciences Star” by LMG Life Sciences
•Listed in “Who’s Who Legal”
•Law 360 Product Liability Editorial Board
•Excellence in Liability Litigation Law Services - USA, CorporateLiveWire
•Named a “Leading lawyer for Product Liability and Mass Tort Defense” by The Legal 500
•John C. Benson Award for Pro Bono Service
•Burton Award for Legal Achievement (honoring his article: Clearing Away the Junk: Court-Appointed Experts, Scientifically Marginal Evidence, and the Silicone Gel Breast Implant Litigation, 56 Food & Drug L.J. 227 (2001))
•Cyber security and Medical Devices (MSBA Food Drug & Device Section, 2016).
•A Checklist Approach to Expert Witnesses (MN CLE, 2015).
•Obesity Litigation: What's Next?, International Foodservice Manufacturers Association, Presidents Conference, Phoenix (2009).
•With Friends Like These: The Changing Role of Medical Journals in Pharmaceutical and Medical Device Litigation, American Conference Institute, Drug & Device Litigation Conference, New York (2006).
•Scientific Evidence in Pesticide Litigation, Pesticide Litigation Manual (2011).
•Scientific Evidence in the 8th Circuit, Scientific Evidence Review (2008).
•The Last Word on Drug Preemption?,Product Liability Law 360 (July 2008).
•FDA's New Guidance For Distributing Articles About Off-Label Uses: Deja Vu All Over Again?,Trends (May 2008).
•Riegel v. Medtronic: A Win For Medical Technology, Product Liability Law 360 (March 2008).
•Beyond the Yuck Factor : Product Liability Implications of Medical Device Reprocessing, Washington Legal Foundation Working Paper Series (2006).
MORE ABOUT PETER GOSS
•Peter J. Goss Discusses Arkansas Supreme Court Ruling on FDA Warning Letter
•Peter J. Goss Discusses E-Discovery Challenges Raised by Takeda Sanctions Ruling
•Peter J. Goss Shares Insights on Johnson & Johnson Hip Settlement
•Peter J. Goss Discusses Maine Drug Importation Law in Law360
•Peter J. Goss Named “Life Sciences Star” in 2013 Edition of Legal Media Group’s Guide to Life Sciences Practitioners
•Peter J. Goss Discusses FDA Evidence in Medical Device Product Liability Cases
•Peter J. Goss Discusses How Bankruptcy May Affect Consolidation of Meningitis Claims in Law 360
•Law 360 Quotes Blackwell Burke P.A. Partner Peter J. Goss on Innovator Liability for Generic Drug Injuries
You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.